Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.825 USD | +1.96% | +12.58% | +219.13% |
31/05 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
31/05 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+219.13% | 461M | |
+53.85% | 55.7B | |
+41.08% | 39.91B | |
-5.79% | 39.57B | |
-5.56% | 28.16B | |
+16.43% | 26.3B | |
-20.24% | 18.94B | |
+32.87% | 12.17B | |
+26.88% | 12.12B | |
+2.18% | 12.12B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study